Navigation Links
Cord Blood America Reports Six Month Financial Results

LOS ANGELES, Aug. 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( focused on bringing the life saving potential of stem cells to families nationwide and internationally, today reported that revenues for the first six months of 2008, ended June 30, totaled $2.4 million.

Revenues were down from the same period in 2007 because of a $1.5 million decrease in revenues at Rainmakers International, the Company's advertising subsidiary. Rainmakers switched business strategies in late 2007, focusing on low cost, high volume, annuity based advertising rather than relying on a few large contracts. Benefits from the change in business plan are slowly being realized.

Gross profit as a percent of revenues increased over the period from 35 to 55 percent, due to a significantly higher proportion of revenue deriving from the Company's primary umbilical cord blood storage business. "I would also urge shareholders to focus on the decrease in the loss from operations, which we have cut in half. I believe this shows our focus and ability to structure a business entity that stands strong on its own," said Matthew Schissler, CEO, Cord Blood America.

"We are dedicated to growing our umbilical cord blood storage business through strategic organic growth and accretive acquisition strategies," Mr. Schissler said. "We remain confident about the future of our Company and its business strategies."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at For investor information, visit


Paul Knopick

E & E Communications


SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Poor Sleep Linked to High Blood Pressure in Teens
2. Air Pollution Can Damage Heart, Blood Vessels, Too
3. White blood cell uses DNA catapult to fight infection
4. Tiny molecule helps control blood-vessel development, UT Southwestern researchers find
5. Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program
6. Gladstone scientists identify single microRNA that controls blood vessel development
7. Too Much Salt Boosts Blood Pressure
8. UCLA and biotech company develop first blood test to measure key hormone that regulates iron
9. Blood Sugar Test May Also Aid Diabetes Detection
10. Blood-Thinner Plavix Works Harder in Smokers
11. Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
Post Your Comments:
(Date:11/26/2015)... , ... November 26, 2015 , ... ... abuse located in central Michigan, have come together on Thanksgiving Day to share ... video, available for viewing on the Serenity Point YouTube channel, patients displayed what ...
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they ... to buy during the Black Friday and Cyber Monday massage chair sales ... the Internet high and low to find the best massage chair deals, they can ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... Ashburn, VA (PRWEB) , ... November 26, 2015 ... ... Planners, an American Express Travel Representative. As a franchise owner, Somu now offers ... range of cruise, destination wedding packages, private cruise sales, as well as, cabin ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... November 26, 2015 3D bioprinting market ... according to a new report by Grand View Research Inc. ... (CKD) which demands kidney transplantation is expected to boost the ... substitute for organ transplantation. --> 3D bioprinting market ... according to a new report by Grand View Research Inc. ...
Breaking Medicine Technology: